Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Suicidal Ideation in Pediatrics
NCT04955470Phase 2Terminated
- Sponsor
- University of British Columbia
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in suicidal ideation, sponsored by University of British Columbia. Primary endpoint: Columbia Suicide Severity Rating Scale at 90 months. Started Jun 2022; status: terminated.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT04955470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04955470.